The Food and Drugs Authority (FDA) has approved two more COVID-19 vaccines for importation, distribution and use in Ghana.
The two new vaccine4s are Moderna (Spikevax) and Pfizer-BioNtech (Cominaty).
This brings the total number of approved COVID-19 vaccines for the use in Ghana to five (5), a statement by the FDA said on Wednesday July 28.
These are “Sputnik V, Covishiled TM, Covid-19 Vaccine Jassen, Moderna (Spikevax, Pfizeer-BioNtech (Comirnaty).”
The FDA said it continues to use the Emergency Use Authorisation (EUA) pathway which is the accepted procedure for all national regulatory authorities globally, in order to ensure timely access to quality and safe medical products including vaccines during this pandemic
“The authority therefore wishes to assure the public that all the approved COVDI-189 vaccines have been subjected to rigorous safety parameters and therefore the public are to receive these vaccines without any reservations.”
- Expanding Africa’s vaccine production capacity key – Noguchi Director
- Dengue fever epidemic declared in Burkina Faso
- Frontiers earned over $87m while government got under $7m from COVID testing at KIA – Report
- I donated PPE worth over $1 million during COVID-19 pandemic – Ken Agyapong
- Ablakwa releases ‘inaccessible details’ of contract awarded to Frontiers for COVID test at the airport
- Read all related articles